Takeda Hid Gout, GERD Drug Interactions: Whistleblower

Law360, New York (January 25, 2012, 7:50 PM EST) -- Takeda Pharmaceutical Co. Ltd. purposely concealed unsafe drug interactions in three treatments for gout and heartburn, causing state and federal governments to overpay for drugs, a former Takeda contractor alleged Wednesday in Massachusetts federal court.

Relator Dr. Helen Ge filed the False Claims Act suit on behalf of the federal government, 24 U.S. states and the District of Columbia, saying Takeda's conduct with respect to its gout treatment Uloric and the gastroesophogeal reflux disease treatments Dexilant and Prevacid steered doctors away from prescribing cheaper generics....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.